Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study – A Randomized Clinical Trial
Advances in Small Animal Medicine and Surgery · 2017-04 · 30 (4) · 1-3
DOI: 10.1016/j.asams.2017.03.008 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Advances in Small Animal Medicine and Surgery, 2017-04. Verfasst von Mark Rishniw. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Rishniw, M. (2017). Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study – A Randomized Clinical Trial. Advances in Small Animal Medicine and Surgery, 30(4), 1-3. https://doi.org/10.1016/j.asams.2017.03.008
Vancouver
Rishniw M. Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study – A Randomized Clinical Trial. Advances in Small Animal Medicine and Surgery. 2017;30(4):1-3. doi:10.1016/j.asams.2017.03.008
BibTeX
@article{Rishniw2017,
author = {Rishniw, Mark},
title = {Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study – A Randomized Clinical Trial},
journal = {Advances in Small Animal Medicine and Surgery},
year = {2017},
volume = {30},
number = {4},
pages = {1--3},
doi = {10.1016/j.asams.2017.03.008}
}
EUVIMED